DelveInsight’s “Antibody-mediated Rejection Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Antibody-mediated Rejec… Read More
HONOLULU — Lung transplant clinicians had a rocky start using belatacept (Nulojix) for immunosuppression at one large-volume center, though they maintained that the agent could sti… Read More
Nulojix (belatacept) is used to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants (medications that suppr… Read More
A new drug to prevent organ rejection after transplantation may also reduce the risk of early death in kidney transplant recipients. The study examined patients who underwent a kidney transp… Read More